[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[C:8](=[O:12])[N:7]([CH2:13][C:14]1[CH:19]=[CH:18][C:17]([S:20]([NH2:23])(=[O:22])=[O:21])=[CH:16][CH:15]=1)[C:6]([C:24](=[O:27])[CH2:25][CH3:26])=[C:5]2[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1.C(N(CC)CC)C.[C:41](=O)([O:47]C(C)(C)C)[O:42][C:43]([CH3:46])([CH3:45])[CH3:44]>CN(C)C1C=CN=CC=1.C(Cl)Cl>[C:43]([O:42][C:41](=[O:47])[NH:23][S:20]([C:17]1[CH:16]=[CH:15][C:14]([CH2:13][N:7]2[C:6]([C:24](=[O:27])[CH2:25][CH3:26])=[C:5]([C:28]3[CH:29]=[CH:30][CH:31]=[CH:32][CH:33]=3)[C:4]3[C:9](=[CH:10][CH:11]=[C:2]([Br:1])[CH:3]=3)[C:8]2=[O:12])=[CH:19][CH:18]=1)(=[O:21])=[O:22])([CH3:46])([CH3:45])[CH3:44]To a mixture of 4-(6-bromo-1-oxo-4-phenyl-3-propionyl-1H-isoquinolin-2-ylmethyl)benzenesulfonamide (2.0 g), triethylamine (1.1 ml), 4-dimethylaminopyridine (0.23 g) and methylene chloride (40 ml) was added di-t-butyl carbonate (1.1 ml) at room temperature with stirring, and the mixture was stirred at the same temperature for 1 hr. After the completion of the reaction, the reaction mixture was washed with 1N hydrochloric acid, and the organic layer was dried over magnesium sulfate and concentrated under reduced pressure. The residue was purified by medium pressure preparative LC (hexane/ethyl acetate=3/1-1/1), crystallized from hexane/ethyl acetate=3/1 to give the title compound (2.0 g) in pale-pink crystals. 1H NMR (CDCl3) δ: 0.46 (3H, t, J=6.9 Hz), 1.37 (9H, s), 1.62 (2H, q, J=6.9 Hz), 5.42 (2H, s), 7.14 (1H, br), 7.24-7.30 (2H, m), 7.39 (2H, d, J=8.4 Hz), 7.29-7.51 (4H, m), 7.69 (1H, dd, J=1.8, 8.4 Hz), 7.95 (2H, d, J=8.4 Hz), 8.41 (1H, d, J=8.4 Hz).